| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $831.5M | -20.0% |
| Cost of Revenue | $377.9M | -27.5% |
| Gross Profit | $453.6M | -12.5% |
| R&D Expense | $179.9M | +1.2% |
| SG&A Expense | $98.9M | -1.5% |
| Operating Income | -$43.0M | -268.2% |
| Pre-tax Income | -$31.6M | -191.0% |
| Income Tax | -$1.9M | -135.0% |
| Net Income | -$29.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.2M | -31.9% |
| Accounts Receivable | $79.3M | -37.1% |
| Inventory | $102.7M | -22.8% |
| Current Assets | $584.7M | -2.2% |
| Total Assets | $939.3M | -0.3% |
| Current Liabilities | $131.1M | -30.1% |
| Total Liabilities | $158.3M | -29.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $68.4M | +21.6% |
| Capital Expenditures | $18.1M | +1.1% |
| Investing Cash Flow | -$109.5M | -1653.9% |
| Financing Cash Flow | $20.9M | +131.7% |
| Free Cash Flow | $50.3M | +31.1% |
| -201.4% |
| EPS (Basic) | -$0.45 | -202.3% |
| EPS (Diluted) | -$0.45 | -207.1% |
| Stockholders' Equity |
| $780.9M |
| +8.6% |